the Board of Directors of the Company has appointed Alain Masse to the newly created position of President, North American Automotive, effective as of the Effective Date.
On June 5, 2025, the Board of Directors (the “Board”) of biote Corp. (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee, appointed Richard R. Barrera to serve as a member of the Board to fill the vacancy created by the prior resignation of Steven J. Heyer
On June 5, 2025, Preston Grasty notified KinderCare Learning Companies, Inc. (the “Company”) that he would be resigning from the Company’s Board of Directors (the “Board”), effective immediately.
Jason C. Murgio was appointed by the Class B Majority Shareholder (as defined below) to the Board to serve as a Designated Director (as defined below).
Departed
Jonathan A. Carnella
Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed
T. Andrew Smith
Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed
Nicholas R. Balzo
Chief Financial Officer and Treasurer
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
Departed
Ann B. Harrington
General Counsel and Secretary
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
Departed
Gregory A. Samay
Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed
Kendall K. Young
Director
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
T. Andrew Smith, Jonathan A. Carnella, Gregory A. Samay and Kendall K. Young each resigned from the Company’s board of directors effective as of the Effective Time.
Departed
Kendall K. Young
Chief Executive Officer and President
NorthStar Healthcare Income, Inc.
Effective
2025-06-09
Filed
June 9, 2025, 7:59 PM ET
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
On June 3, 2025, the Board of Directors of Applied Energetics expanded its number to seven members and appointed Christopher Donaghey and Scott Andrews to serve as new directors., effective immediately.
On June 3, 2025, the Board of Directors of Applied Energetics expanded its number to seven members and appointed Christopher Donaghey and Scott Andrews to serve as new directors., effective immediately.
On June 5, 2025, the Board of Directors (the “ Board ”) of the Company, with the recommendation of the Nominating and Corporate Governance Committee, appointed Ms. Saundra Pelletier as a member of the Board.
On and effective June 5, 2025, the Board of Directors of First Western Financial, Inc. (the “Company”) appointed Matthew C. Cassell to serve as Chief Revenue Officer of First Western Trust Bank (the “Bank”).
Departed
Gordon M. Burns
Director
Compass Group Diversified Holdings LLC
Effective
2025-06-07
Filed
June 9, 2025, 7:59 PM ET
on June 7, 2025, Mr. Burns notified the Trust and the Board of his intent to resign as a director of the Company, effective June 7, 2025.
On June 5, 2025, Daniel S. Devorsetz stepped down as Chief Investment Officer and Chief Operating Officer of Horizon Technology Finance Corporation (the “ Company ”.
On June 5, 2025, Daniel S. Devorsetz stepped down as Chief Investment Officer and Chief Operating Officer of Horizon Technology Finance Corporation (the “ Company ”.
On June 9, 2025, FibroBiologics, Inc. (the “Company”) announced that Jason D. Davis has been appointed as the Company’s Chief Financial Officer, effective as of June 9, 2025 (the “Effective Date”).
On June 3, 2025, the Board of Directors of Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), approved the appointment of Dr. Kaouthar Lbiati, a director of the Company, as interim Chief Executive Officer, effective June 16, 2025.
Mr. Michael W. Sumruld will join the Company as Senior Vice President of Finance on September 1, 2025, and is expected to succeed Mr. Curtis as Chief Financial Officer upon Mr. Curtis’s retirement from such position.
On June 3, 2025, Thomas J. Snyder, President of Silgan Containers, the U.S. metal container operations of Silgan Holdings Inc., or the Company, notified the Company that he was resigning from his position with Silgan Containers to pursue another opportunity.
On June 3, 2025, the Board appointed Steven F. Mayer to the Board as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, effective immediately prior to, and contingent upon, the effectiveness of the Financing Agreement.
On June 4, 2025, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) increased the size of the Board from nine (9) to ten (10) directors and unanimously appointed Maha Radhakrishnan, M.D., to fill the newly created vacancy on the Board, effective June 4, 2025.
Departed
David Shook
Chief Medical Officer and Head of Research & Development
David Shook, M.D. notified Nkarta, Inc. (the “Company”) of his decision to resign as Chief Medical Officer and Head of Research & Development of the Company to pursue other opportunities in the oncology space.
Appointed
Shawn Rose
Chief Medical Officer and Head of Research and Development
Shawn Rose, M.D. Ph.D. has been appointed by the Company to succeed Dr. Shook as Chief Medical Officer and Head of Research and Development starting on June 23, 2025.
Departed
Shahram Ghasemian
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
On June 5, 2025, Mr. Shahram Ghasemian, Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of Centrus Energy Corp. (the “Company”) provided notice that he will resign from his positions at the Company, effective June 29, 2025, in order to pursue another opportunity.
Appointed
(interim)
Richard Emery
Acting General Counsel, Chief Compliance Officer & Corporate Secretary
Effective upon Mr. Ghasemian's departure, Mr. Richard Emery will be appointed as Acting General Counsel, Chief Compliance Officer & Corporate Secretary of the Company.
On June 5, 2025, Kurt Darrow, who has served as a member of the CMS Energy Corporation (“CMS Energy”) and Consumers Energy Company (“Consumers”) Boards of Directors (“Boards”) since 2013, informed CMS Energy and Consumers that he has decided to retire from the Boards, effective July 1, 2025.
Appointed
Chen Yi (Jean) Hsu
trustee
Antares Strategic Credit Fund
Effective
2025-06-02
Filed
June 6, 2025, 7:59 PM ET
Effective as of June 2, 2025, Chen Yi (Jean) Hsu was appointed by the Board of Trustees (the “ Board ”) of Antares Strategic Credit Fund (the “ Company ”) as a trustee.
Appointed
Chen Yi (Jean) Hsu
trustee
Antares Private Credit Fund
Effective
2025-06-02
Filed
June 6, 2025, 7:59 PM ET
Effective as of June 2, 2025, Chen Yi (Jean) Hsu was appointed by the Board of Trustees (the “ Board ”) of Antares Private Credit Fund (the “ Company ”) as a trustee.
On June 2, 2025, Brent Rhodes notified Hub Group, Inc. (the "Company") of his decision to resign from the position of Chief Accounting Officer effective June 27, 2025 ("Effective Date").
On June 4, 2025, the Board of Directors (the “Board”) of Kestra Medical Technologies, Ltd. (the “Company”) elected Mr. Conor Hanley as a new member of the Board.
On June 6, 2025, Tralisa Maraj, the Chief Financial Officer of LiveWire Group, Inc. (the “Company”), announced her resignation effective July 11, 2025 allowing sufficient time for a transition of her responsibilities before pursuing another opportunity outside the Company.
Departed
Courtney Conigliaro
Chief Financial Officer
OACC ·
Oaktree Acquisition Corp. III Life Sciences
Effective
2025-06-03
Successor
Thomas Sweeney
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
Appointed
Thomas Sweeney
Chief Financial Officer
OACC ·
Oaktree Acquisition Corp. III Life Sciences
Effective
2025-06-03
Filed
June 6, 2025, 7:59 PM ET
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
On June 5, 2025, the Board of Directors (the “Board”) of Ludwig Enterprises, Inc. (the “Company”) received a letter of resignation from Dr. Marvin S. Hausman from his position on the Board, Dr. Hausman will remain in his position as Chief Scientific Officer of the Company.
On June 2, 2025, Bruno Leonardo Kmita de Oliveira Passos resigned from his role as a member of the Board of Directors of Hashdex Asset Management Ltd. (the “Sponsor”), the sponsor of the Hashdex Nasdaq Crypto Index US ETF (the “Trust”).
As previously disclosed, effective June 6, 2025, Natalie Russell, the Company’s Director of Accounting, will serve as the Company’s Interim Chief Financial Officer.
Effective June 6, 2025, Donald Alvarez stepped down as a member of the board of directors (the “Board”) and Chief Financial Officer of Cyngn Inc. (the “Company”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.